• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Selected Transactions


Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (106)
  • (96)
  • (47)

Deal Type

  • (298)
  • (141)
  • (140)
  • (7)

Clear all Apply

Bryan, Garnier & Co successfully advises the sale of ORNIS to RISC Group

ORNIS tombstone

Bryan, Garnier & Co successfully leads a €53.5 million follow-on offering for Risc Group

Risc Group tombstone

Bryan, Garnier & Co successfully leads a €40 million private placement in public equity for BioAlliance

BioAlliance tombstone

Bryan, Garnier & Co successfully leads a €100.1 million capital increase for Transgene

Transgene 2007 tombstone

Bryan, Garnier & Co successfully leads the secondary placement of 20.5% of NetBooster shares

NetBooster tombstone

Bryan, Garnier & Co successfully advises AS INFOR’s shareholders on the sale of the company to CEGID Group

AS INFOR tombstone

Bryan, Garnier & Co leads €45 million secondary placement of Parrot shares on Euronext

Parrot tombstone

Bryan, Garnier & Co successfully advised Influe shareholders in their merger with Generix

Influe tombstone

Bryan, Garnier & Co successfully leads a €66.1 million capital increase for Sword Group

Sword Group 2007 tombstone

Bryan Garnier & Co leads €15 million IPO of the first internet up-market wines retailer on Alternext, Euronext’s alternative investment market

1855 tombstone

Bryan, Garnier & Co successfully leads a €33.7 million IPO for Innate Pharma

Innate Pharma 2006 tombstone

Bryan Garnier & Co successfully leads a EUR 19.1 million follow-on offering for Risc Group (Euronext: RSC)

Risc Group 2006 tombstone
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }